{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:00:41Z","timestamp":1775246441679,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["9403191394"],"award-info":[{"award-number":["9403191394"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12865-017-0226-8","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T08:11:12Z","timestamp":1503475872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-3757","authenticated-orcid":false,"given":"Manoochehr","family":"Karami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pegah","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal","family":"Bathaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Berangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Pashaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Zahiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohsen","family":"Zahraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Erfani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Ponnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"issue":"Suppl 4","key":"226_CR1","first-page":"49","volume":"60","author":"AR Hinman","year":"2011","unstructured":"Hinman AR, Orenstein WA, Schuchat A, Control CfD, Prevention. Vaccine-preventable diseases, immunizations, and MMWR: 1961\u20132011. MMWR Surveill Summ. 2011;60(Suppl 4):49\u201357.","journal-title":"MMWR Surveill Summ"},{"issue":"2","key":"226_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1201-9712(03)90011-7","volume":"7","author":"J Ar\u00edstegui","year":"2003","unstructured":"Ar\u00edstegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, Bock HL. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis. 2003;7(2):143\u201351.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"226_CR3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a010145","volume":"151","author":"G Serres De","year":"2000","unstructured":"De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol. 2000;151(11):1039\u201348. discussion 1049\u20131052","journal-title":"Am J Epidemiol"},{"key":"226_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/oxfordjournals.epirev.a036066","volume":"13","author":"ED Shapiro","year":"1990","unstructured":"Shapiro ED, Ward JI. The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Epidemiol Rev. 1990;13:113\u201342.","journal-title":"Epidemiol Rev"},{"key":"226_CR5","unstructured":"WHO Global Programme for Vaccines and Immunization. The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Weekly Epidemiological Record. 1998;73(10):64\u201368."},{"issue":"3","key":"226_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tmaid.2014.04.004","volume":"12","author":"V Gallego","year":"2014","unstructured":"Gallego V, Berberian G, Lloveras S, Verbanaz S, Chaves TS, Orduna T, Rodriguez-Morales AJ. The 2014 FIFA world cup: communicable disease risks and advice for visitors to Brazil--a review from the Latin American Society for Travel Medicine (SLAMVI). Travel Med Infect Dis. 2014;12(3):208\u201318.","journal-title":"Travel Med Infect Dis"},{"issue":"49","key":"226_CR7","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1016\/j.vaccine.2013.09.015","volume":"31","author":"EJ Asturias","year":"2013","unstructured":"Asturias EJ, Contreras-Roldan IL, Ram M, Garcia-Melgar AJ, Morales-Oquendo V, Hartman K, Rauscher M, Moulton LH, Halsey NA. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children. Vaccine. 2013;31(49):5909\u201314.","journal-title":"Vaccine"},{"issue":"9","key":"226_CR8","first-page":"506","volume":"13","author":"LE Happe","year":"2007","unstructured":"Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S. Combination vaccine use and vaccination quality in a managed care population. Am J Manag Care. 2007;13(9):506\u201313.","journal-title":"Am J Manag Care"},{"issue":"11","key":"226_CR9","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00006454-200111001-00002","volume":"20","author":"MD Decker","year":"2001","unstructured":"Decker MD. Principles of pediatric combination vaccines and practical issues related to use in clinical practice. Pediatr Infect Dis J. 2001;20(11):S10\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"226_CR10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","volume":"25","author":"H Kalies","year":"2006","unstructured":"Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt H-J, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J. 2006;25(6):507\u201312.","journal-title":"Pediatr Infect Dis J"},{"key":"226_CR11","volume-title":"Guideline for adverse events following immunization","author":"A Esteghamati","year":"2005","unstructured":"Esteghamati A, Salar Amoli M, Fatemeh A. Guideline for adverse events following immunization. 3th ed. Tehran: Department of Disease Management in Health Ministry; 2005.","edition":"3"},{"issue":"2","key":"226_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14760584.2014.866895","volume":"13","author":"NW Crawford","year":"2014","unstructured":"Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP. Active surveillance for adverse events following immunization. Expert Rev Vaccines. 2014;13(2):265\u201376.","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"226_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/14760584.2015.1029460","volume":"14","author":"S Tafuri","year":"2015","unstructured":"Tafuri S, Gallone MS, Calabrese G, Germinario C. Adverse events following immunization: is this time for the use of WHO causality assessment? Expert Rev Vaccines. 2015;14(5):625\u20137.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"226_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.vaccine.2011.11.067","volume":"30","author":"HJ Sharma","year":"2012","unstructured":"Sharma HJ, Patil VD, Lalwani SK, Manglani MV, Ravichandran L, Kapre SV, Jadhav SS, Parekh SS, Ashtagi G, Malshe N. Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process. Vaccine. 2012;30(3):510\u20136.","journal-title":"Vaccine"},{"issue":"1","key":"226_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1995.tb44436.x","volume":"754","author":"RA Insel","year":"1995","unstructured":"Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine componentsa. Ann N Y Acad Sci. 1995;754(1):35\u201348.","journal-title":"Ann N Y Acad Sci"},{"key":"226_CR16","doi-asserted-by":"crossref","unstructured":"Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). The Cochrane database of systematic reviews 2009(3):Cd005530.","DOI":"10.1002\/14651858.CD005530.pub2"},{"issue":"2","key":"226_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/CVI.00541-12","volume":"20","author":"Y Hu","year":"2013","unstructured":"Hu Y, Li Q, Lin L, Chen E, Chen Y, Qi X. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China. Clin Vaccine Immunol. 2013;20(2):211\u20137.","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"226_CR18","first-page":"33","volume":"1","author":"M Karami","year":"2006","unstructured":"Karami M, Holakouie Naieni K, Rahimi A, Fotouhi A, Eftekhar Ardabili H. Adverse events following immunization with DTP vaccine in infants and children in Kermanshah city: a cohort study. Iran J Epidemiol. 2006;1(3):33\u20139.","journal-title":"Iran J Epidemiol"},{"issue":"4","key":"226_CR19","first-page":"245","volume":"11","author":"M Nabavi","year":"2010","unstructured":"Nabavi M, Jandaghi J, Ghorbani R, Khaleghi Hashemian M, Shojaee H, Maherbonabi S, Mohammadzade F, Ghadamyari M, Bayat S, Faraji Z. The incidence of complications of vaccination in children and infants of Semnan, Iran. Koomesh. 2010;11(4):245\u201354.","journal-title":"Koomesh"},{"issue":"2","key":"226_CR20","first-page":"1","volume":"7","author":"R Sharafi","year":"2016","unstructured":"Sharafi R, Mortazavi J, Heidarzadeh A. Comparison of complications of pentavalent and DTP vaccination in infants aged 2\u20136 months in Anzali, Iran. Iran J Neonatology IJN. 2016;7(2):1\u20136.","journal-title":"Iran J Neonatology IJN"},{"issue":"1","key":"226_CR21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13312-017-0989-2","volume":"54","author":"J Chhatwal","year":"2017","unstructured":"Chhatwal J, Lalwani S, Vidor E. Immunogenicity and safety of a liquid Hexavalent vaccine in Indian infants. Indian Pediatr. 2017;54(1):15\u201320.","journal-title":"Indian Pediatr"},{"issue":"5","key":"226_CR22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/14760584.2017.1303380","volume":"16","author":"YX Wang","year":"2017","unstructured":"Wang YX, Tao H, Hu JL, Li JX, Dai WM, Sun JF, Liu P, Tang J, Liu WY, Zhu FC. The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3\u20135 months. Expert Rev Vaccines. 2017;16(5):515\u201324.","journal-title":"Expert Rev Vaccines"},{"key":"226_CR23","doi-asserted-by":"crossref","unstructured":"Sadoh AE, Nwaneri DU, Ogboghodo BC, Sadoh WE. Comparison of adverse events following pentavalent and diphtheria-tetanus-pertussis vaccines among Nigerian children. Pharmacoepidemiol Drug Saf. 2017:1\u20134.","DOI":"10.1002\/pds.4243"},{"issue":"7","key":"226_CR24","first-page":"58","volume":"10","author":"A Hashemi","year":"2016","unstructured":"Hashemi A, Taheri Soodejani M, Karami M, Rahimi Pordanjani S. Adverse effects of influenza vaccination among healthcare staff in shiraz in 2014, Iran. Qom Univ Med Sci J. 2016;10(7):58\u201364.","journal-title":"Qom Univ Med Sci J"}],"updated-by":[{"DOI":"10.1186\/s12865-017-0228-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000}}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-017-0226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T08:11:29Z","timestamp":1503475889000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-017-0226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1186\/s12865-017-0226-8","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12865-017-0228-6","asserted-by":"object"}]},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,23]]},"article-number":"42"}}